Detalhe da pesquisa
1.
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Antimicrob Agents Chemother
; 58(9): 5332-41, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24982076
2.
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.
Hepatology
; 51(4): 1122-6, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20069649
3.
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.
J Hepatol
; 52(5): 652-7, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20346533
4.
Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.
Hepatology
; 49(4): 1151-7, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19115222
5.
Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin.
Antivir Ther
; 14(4): 501-11, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19578235
6.
Interferon therapy for chronic hepatitis B.
Clin Liver Dis
; 11(4): 839-49, viii, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17981231
7.
Impact of ribavirin dose on retreatment of chronic hepatitis C patients.
World J Gastroenterol
; 18(23): 2966-72, 2012 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22736920
8.
Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirin.
Antivir Ther
; 17(5): 927-32, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22611092
9.
[Treatment of patients with chronic hepatitis C who have not been previously treated]. / Traitement des malades atteints d'hépatite chronique C n'ayant jamais été traités.
Gastroenterol Clin Biol
; 26 Spec No 2: B194-201, 2002 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-12180288
10.
Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2a.
Antivir Ther
; 14(8): 1183-8, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-20032548
11.
High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapy.
J Hepatol
; 46(4): 596-604, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17218037
12.
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up.
Hepatology
; 44(3): 728-35, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16941695
13.
Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy.
Cytokine
; 17(2): 108-17, 2002 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-11886178